FDA Advisory Board Approves First Over-the-Counter Birth Control Pill

This week an FDA advisory board paved the way for the first over the counter birth control pill, with an unanimous decision 17-0. The FDA must accept the recommendation before the pills are available for sale, which is expected in a few months time. If approved, the progestin-only pill would be manufactured by the company Perrigo, under the brand name Opill.

Ira talks with Maggie Koerth, science journalist based in Minneapolis, Minnesota, about that and more including; Voyager spacecrafts get energy boosts, wild axolotls face extinction, testing airplane waste for COVID-19 and more.

Just over three years ago, Alex Azar, then the Secretary of Health and Human Services, issued a declaration of a national public health emergency as a result of the novel coronavirus, SARS-CoV-2. That declaration kicked off a cascade of nationwide funding, policies, and restrictions aimed at combating the spread of the COVID-19 pandemic.

In the three years that followed, the Centers for Disease Control and Prevention estimates over a million people in the US have died from COVID-19.

Yesterday, although the virus is still circulating and people are still getting sick, that emergency declaration finally came to an end, after being renewed over a dozen times. A statement released by the Department of Health and Human Services said “COVID-19 is no longer the disruptive force it once was. Since January 2021, COVID-19 deaths have declined by 95% and hospitalizations are down nearly 91%.”

Dr. Anthony Fauci, former head of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, joins Ira Flatow to talk about where we go from here. Is life back to normal—or is there a new normal? What have we learned from the past three years about responding to future outbreaks?

Transcripts for each segment will be available the week after the show airs on sciencefriday.com.

Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.